Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxacillin
Drug ID BADD_D01631
Description An antibiotic similar to [flucloxacillin] used in resistant staphylococci infections.
Indications and Usage Used in the treatment of resistant staphylococci infections.
Marketing Status approved; investigational
ATC Code J01CF04
DrugBank ID DB00713
KEGG ID D08307
MeSH ID D010068
PubChem ID 6196
TTD Drug ID D0MB8I
NDC Product Code 64679-699; 64679-700; 0338-1013; 63323-812; 82449-506; 0338-1015; 64679-698; 72485-409; 63323-813; 66794-227
UNII UH95VD7V76
Synonyms Oxacillin | Penicillin, Methylphenylisoxazolyl | Methylphenylisoxazolyl Penicillin | Oxazocilline | Oxacillin, Monosodium Salt, Monohydrate | Prostaphlin | Oxacillin Sodium | Sodium, Oxacillin | Oxacillin, Monosodium Salt, Anhydrous | Sodium Oxacillin | Oxacillin, Sodium
Chemical Information
Molecular Formula C19H19N3O5S
CAS Registry Number 66-79-5
SMILES CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001---
Abdominal pain07.01.05.0020.000049%
Agranulocytosis01.02.03.001---
Amnesia17.03.02.001; 19.20.01.0010.000049%
Anaphylactic shock10.01.07.002; 24.06.02.0040.000049%-
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Arthralgia15.01.02.001--
Aspartate aminotransferase increased13.03.04.011--
Body temperature increased13.15.01.001---
Bronchospasm10.01.03.012; 22.03.01.004--
Chills08.01.09.001; 15.05.03.0160.000049%
Circulatory collapse24.06.02.001---
Clostridium difficile colitis07.19.01.004; 11.02.02.004---
Colitis07.08.01.001--
Cyanosis02.11.04.004; 22.02.02.007; 23.06.04.005; 24.03.01.0070.000049%
Death08.04.01.001--
Dermatitis23.03.04.002---
Diarrhoea07.02.01.001--
Discomfort08.01.08.003---
Eosinophilia01.02.04.0010.000107%
Erythema23.03.06.0010.000049%-
Feeling abnormal08.01.09.014---
Gait disturbance08.01.02.002; 15.03.05.013; 17.02.05.0160.000049%
Gastrointestinal disorder07.11.01.001---
Gastrointestinal pain07.01.05.005--
Haematuria20.02.01.006; 21.10.01.018; 24.07.01.047--
Haemolytic anaemia01.06.03.0020.000049%-
Headache17.14.01.0010.000073%
Hepatotoxicity09.01.07.009; 12.03.01.008---
Hypersensitivity10.01.03.003--
The 1th Page    1 2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene